Record
revenue in 2018 of €3.1bn
2018 organic growth of +2.6% and +2.9% in
Q4
2018 pro forma organic growth of +2.4%
The 2018 organic
growth reflects the solid performance of Elis' historic scope and
the smooth integration of Berendsen's countries with an
acceleration of the Group's pro forma organic growth in H2
-
Improving trend in the United Kingdom throughout
the year: The actions that have been implemented are bearing fruit
with rising prices and fewer contract losses
-
More than +2% growth in France, driven by good
commercial momentum despite the impact of the Yellow Vests movement
on Hospitality in Paris in December
-
Sequential acceleration in Central Europe, with
some improvement in Germany and Switzerland in H2
-
Continued commercial momentum in Scandinavia and
Southern Europe
-
Strong growth in Brazil despite the decrease of
inflation
-
Currency impact over the year: -1.8% pro forma
or €55.5mn
Saint Cloud,
January 30, 2019 - Elis, an international multi-service
provider, offering textile, hygiene and facility services solutions
across 28 countries in Europe and Latin America, today announces
its full-year 2018 revenue. These figures are unaudited.
Commenting on the full-year
revenue, Xavier Martiré, CEO of Elis,
said:
"In 2018 Elis'
revenue reached a record at more than €3.1bn, driven by the
acquisition of Berendsen that is being integrated in a very
satisfying way. The pro forma organic growth of +2.4% all along the
year was supported by a better than expected 4th
quarter, progressing by nearly +3% on an organic basis.
The sales
dynamics observed in all our geographies highlight the relevance of
our strategy and the resilience of our activity in the countries in
which market conditions are more difficult.
Elis' historic
scope recorded satisfying levels of growth: In France, growth is
above +2% despite the impact of the Yellow Vests movement in
December. In Southern Europe, growth remains above +3% in spite of
the slowdown observed in Hospitality in Spain during the summer. In
Berendsen's geographies, Scandinavia continues its good momentum
with organic growth of more than +3%. In the United Kingdom,
the measures implemented to improve quality of
service have borne fruit and allowed us to reduce the churn rate
and to increase prices. The trend has improved throughout the year,
with slightly positive organic growth in Q4, compared to -3% one
year ago. In Central Europe, the only geography where there was
overlap between Elis and Berendsen before the acquisition, growth
is up +2%. Growth is high in Poland and the Netherlands, and
remains slower in Germany and Switzerland, although we observed
encouraging trends in H2. Finally, Latin America posted organic
growth of more than 8%. The market remains very dynamic despite the
decrease of inflation in Brazil, and we continue to open the market
in these countries with high growth potential.
As usual, we will
provide guidance for 2019 when we release our full-year 2018
results on March 7th,
2019."
In H1 2018 the
Group initiated the sale process for its Clinical Solutions
(operating only in the United Kingdom) and anticipates that the
sale will occur in the next 6 months. The figures disclosed in the
present press release exclude the Clinical Solutions activity for
both 2017 and 2018.
2018 reported
revenues (with Berendsen consolidated from 1st
September 2017)
(EUR
million) |
H1 |
2018
H2 |
FY |
H1 |
2017
H2 |
FY |
H1 |
Var.
H2 |
FY |
France |
505.9 |
526.9 |
1,032.8 |
494.6 |
514.4 |
1,009.0 |
+2.3% |
+2.4% |
+2.4% |
Central Europe |
328.7 |
353.4 |
682.1 |
130.4 |
258.4 |
388.8 |
+152.0% |
+36.8% |
+75.4% |
Scandinavia & East. Eur. |
240.8 |
243.1 |
483.8 |
- |
164.2 |
164.2 |
n/a |
+48.0% |
+194.6% |
United Kingdom &
Ireland |
196.6 |
201.1 |
397.8 |
- |
131.2 |
131.2 |
n/a |
+53.3% |
+203.2% |
Southern Europe |
126.9 |
141.1 |
268.0 |
123.8 |
135.3 |
259.1 |
+2.5% |
+4.3% |
+3.5% |
Latin America |
125.5 |
122.2 |
247.7 |
87.5 |
133.7 |
221.2 |
+43.4% |
-8.6% |
+12.0% |
Others |
9.6 |
11.4 |
21.0 |
9.4 |
10.7 |
20.0 |
+2.0% |
+7.3% |
+4.8% |
Total |
1,533.9 |
1,599.3 |
3,133.3 |
845.8 |
1,347.9 |
2,193.6 |
+81.4% |
+18.7% |
+42.8% |
« Others » includes Manufacturing Entities and
Holdings.
Percentage change calculations are based on actual
figures.
Reported organic
revenue growth
(EUR million) |
H1 organic growth |
H2 organic growth |
2018 organic growth |
France |
+1.9% |
+2.4% |
+2.2% |
Central Europe |
-1.1% |
+1.9% |
+0.9% |
Scandinavia & East. Eur. |
n/a |
+2.7% |
+2.7% |
United Kingdom &
Ireland |
n/a |
-0.6% |
-0.6% |
Southern Europe |
+2.5% |
+3.9% |
+3.2% |
Latin America |
+13.5% |
+5.1% |
+8.4% |
Others |
-5.4% |
+4.7% |
-0.1% |
Total |
+2.7% |
+2.5% |
+2.6% |
« Others » includes Manufacturing Entities and
Holdings.
Percentage change calculations are based on actual
figures.
Revenues, pro
forma for the acquisition of Berendsen (as if Berendsen was
consolidated on 1st January
2017)
(EUR
million) |
H1 |
2018
H2 |
FY |
H1 |
2017
H2 |
FY |
H1 |
Var.
H2 |
FY |
France |
505.9 |
526.9 |
1,032.8 |
494.6 |
514.4 |
1,009.0 |
+2.3% |
+2.4% |
+2.4% |
Central Europe |
328.7 |
353.4 |
682.1 |
320.0 |
320.9 |
640.9 |
+2.6% |
+10.1% |
+6.4% |
Scandinavia & East. Eur. |
240.8 |
243.1 |
483.8 |
240.4 |
243.9 |
484.3 |
+0.1% |
-0.3% |
-0.1% |
United Kingdom &
Ireland |
196.6 |
201.1 |
397.8 |
204.3 |
201.6 |
406.0 |
-3.9% |
-0.2% |
-2.0% |
Southern Europe |
126.9 |
141.1 |
268.0 |
123.8 |
135.3 |
259.1 |
+2.5% |
+4.3% |
+3.5% |
Latin America |
125.5 |
122.2 |
247.7 |
87.5 |
133.7 |
221.2 |
+43.4% |
-8.6% |
+12.0% |
Others |
9.6 |
11.4 |
21.0 |
9.9 |
10.2 |
20.2 |
-4.1% |
+12.2% |
+4.1% |
Total |
1,533.9 |
1,599.3 |
3,133.3 |
1,480.5 |
1,559.9 |
3,040.5 |
+3.6% |
+2.5% |
+3.0% |
« Others » includes Manufacturing Entities and
Holdings.
Percentage change calculations are based on actual
figures.
2018 organic
revenue growth, pro forma for the acquisition of Berendsen (as if
Berendsen was consolidated from 1st January
2017)
(EUR million) |
H1 organic growth |
H2 organic growth |
2018 organic growth |
France |
+1.9% |
+2.4% |
+2.2% |
Central Europe |
+0.9% |
+3.1% |
+2.0% |
Scandinavia & East. Eur. |
+3.3% |
+2.9% |
+3.1% |
United Kingdom &
Ireland |
-2.0% |
-0.3% |
-1.1% |
Southern Europe |
+2.5% |
+3.9% |
+3.2% |
Latin America |
+13.5% |
+5.1% |
+8.4% |
Others |
-5.1% |
+13.9% |
+4.5% |
Total |
+2.1% |
+2.7% |
+2.4% |
« Others » includes Manufacturing Entities and
Holdings.
Percentage change calculations are based on actual
figures.
2018 Q4 revenues,
pro forma for the acquisition of Berendsen (as if Berendsen was
consolidated on 1st January
2017)
(EUR million) |
2018 |
2017 |
Reported growth |
Organic growth |
France |
254.9 |
247.2 |
+3.1% |
+3.1% |
Central Europe |
176.6 |
160.2 |
+10.2% |
+3.1% |
Scandinavia & East. Eur. |
125.7 |
124.4 |
+1.0% |
+3.4% |
United Kingdom &
Ireland |
98.9 |
98.4 |
+0.5% |
+0.5% |
Southern Europe |
64.6 |
60.2 |
+7.4% |
+6.3% |
Latin America |
62.9 |
66.6 |
-5.6% |
+2.6% |
Others |
5.2 |
6.3 |
-17.1% |
-17.2% |
Total |
788.7 |
763.3 |
+3.3% |
+2.9% |
« Others » includes Manufacturing Entities and
Holdings.
Percentage change calculations are based on actual
figures.
France
In 2018, France organic growth is
+2.2%. This illustrates the quality of the French market, where we
continue to gain market share, in a price environment that is now
slightly favorable.
In Q4, we posted organic growth of
+3.1%, despite the impact of the Yellow Vests movement on our
Hospitality activity, which we estimate at c.1.5m€ for the month of
December. This good performance is mainly explained by a positive
calendar effect, reversing the one observed in Q3 2018.
Central
Europe
In 2018, Central Europe pro forma
organic growth is +2.0%, with good commercial momentum in Poland
and the Netherlands. Germany grew slightly, and the situation is
improving in Switzerland, although revenue is still slightly
down.
In Q4, organic growth is up +3.1%,
confirming the rebound in activity observed in Q3 after a
challenging first half. Germany benefited from a positive price
dynamic in Healthcare, the sector in which we are focusing our
efforts in terms of acquisitions.
Scandinavia &
Eastern Europe
In 2018, commercial momentum
remained good in Scandinavia and pro forma organic growth stood at
+3.1%. All the countries posted growth, sustainably for some
countries (Russia, Baltics, Finland and Sweden) and in a more
limited way for some others (Denmark, Norway). Exchange rate
variations had a negative impact of -3.2% over the year.
In Q4, the organic growth was up
+3.4% with a positive calendar effect reversing the one observed in
Q3 2018.
United Kingdom
and Ireland
In 2018, organic revenue of the
United Kingdom & Ireland zone is down -1.1% in pro
forma(compared to -2.9% last year). Since the acquisition of
Berendsen, Elis has launched several actions in Hospitality
designed to (i) limit contract losses due to clients dissatisfied
with the quality of service delivered by Berendsen before the
acquisition and (ii) increase the prices of some contracts on which
Berendsen had agreed to steep discounts. In the Workwear segment,
in which prices are at good level, attention was paid to client
retention. The sequential improvement of organic growth observed
all along the year illustrates the efficiency of the measures that
have been put in place.
In Q4, the zone's organic growth
is up +0.5%, reflecting the improvement of our situation in
Hospitality.
Southern
Europe
In 2018, revenue growth in
Southern Europe was up +3.5%, with organic growth of +3.2%. This
performance is again driven by Portugal (+7.5% organic growth). In
Spain, despite the slowdown in Hospitality observed during the
summer, which benefited such destinations as the Maghreb countries,
Greece or Turkey, the country posted organic growth of +2.5%,
mainly driven by additional market share gains.
In Q4 organic growth in the region
was +6.3%, with a positive calendar effect reversing the one
observed in Q3 2018 and a slight rebound recorded in Spain.
Latin
America
In 2018, revenue in Latin America
grew by +12.0%, with organic growth of +8.4%, an impact of +18.2%
from acquisitions and a negative foreign exchange effect of -14.7%.
Commercial momentum remains good in Brazil both on prices and
commercial development.
In Q4, the region's organic growth
was +2.6%, with decreasing inflation in Brazil and the non-renewal
of a few contracts in Healthcare.
Financial definitions
Organic growth in the Group's
revenue is calculated excluding (i) the impacts of changes in the
scope of consolidation of "major acquisitions" and "major
disposals" (as defined in the Document de
Base) in each of the periods under comparison, as well as (ii)
the impact of exchange rate fluctuations.
Geographical breakdown
-
France
-
Central Europe: Germany, Netherlands,
Switzerland, Poland, Belgium, Austria, Czech Republic, Hungary,
Slovakia, Luxembourg
-
Scandinavia & Eastern Europe: Sweden,
Denmark, Norway, Finland, Latvia, Estonia, Lithuania, Russia
-
UK & Ireland
-
Southern Europe: Spain & Andorra, Portugal,
Italy
-
Latin America: Brazil, Chile, Colombia
Presentation of Elis' full-year
2018 results (in English)
Date:
Thursday 7 March 2019 - 8:30am London time (9:30am Paris time)
Venue:
Four Seasons Trinity Square, 10 Trinity Square, London EC3N 4AJ
The investors who would like to
attend the presentation are required to contact us by
e-mail:
investors@elis.com
Forward looking
statements
This document may contain
information related to the Group's outlook. Such outlook is based
on data, assumptions and estimates that the Group regarded as
reasonable at the date of this press release. Those data and
assumptions may change or be adjusted as a result of uncertainties
relating particularly to the economic, financial, competitive,
regulatory or tax environment or as a result of other factors of
which the Group was not aware on the date of this press release.
Moreover, the materialization of certain risks described in chapter
2 "Risk factors and insurance policy" of the Registration Document
may have an impact on the Group's activities, financial position,
results or outlook and therefore threaten this outlook. The
attainment of the outlook also assumes that the Group's strategy
will be successful. As a result, the Group makes no representation
and gives no warranty regarding the attainment of any outlook set
out above.
Contact
Nicolas Buron, Investor
Relations Director - Phone: +33 175 499 830 -
nicolas.buron@elis.com
Audrey Bourgeois, Investor Relations - Phone:
+ 33 175 499 625 - audrey.bourgeois@elis.com
Elis - 2018 full-year
revenue
This
announcement is distributed by West Corporation on behalf of West
Corporation clients.
The issuer of this announcement warrants that they are solely
responsible for the content, accuracy and originality of the
information contained therein.
Source: Elis via Globenewswire
Elis (EU:ELIS)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Elis (EU:ELIS)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024